Status:
UNKNOWN
Inflammation and Clotting Abnormalities in Aneurysmal Coronary Artery Disease
Lead Sponsor:
John Paul II Hospital, Krakow
Collaborating Sponsors:
Jagiellonian University
National Science Centre, Poland
Conditions:
Coronary Artery Aneurysm
Abdominal Aortic Aneurysm
Eligibility:
All Genders
18-85 years
Brief Summary
The main objective of the CARE-ANEURYSM project is to evaluate inflammation and clotting abnormalities in patients with aneurysmal coronary artery disease in relation to patients with abdominal aortic...
Detailed Description
The trial will enrol 180 patients, 60 in each of three groups: 1) aneurysmal coronary artery disease; 2) abdominal aortic aneurysm; 3) coronary artery disease. In addition, up to 250 patients with ane...
Eligibility Criteria
Inclusion
- Age 18-85 years old
- Angiographically confirmed coronary artery ectasia or aneurysm (Arm I)
- Abdominal aortic aneurysm (Arm II)
- Angiographically confirmed coronary artery disease (Arm III)
Exclusion
- Less than 12 months from ACS
- Actual oral anticoagulant therapy
- Actual antiplatelet therapy other than aspirin
- Heart failure NYHA IV
- Untreated hyperthyroidism or hypothyroidism
- Severe comorbidities
- Lack of consent
Key Trial Info
Start Date :
January 10 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2025
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT05183373
Start Date
January 10 2022
End Date
September 30 2025
Last Update
January 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Cardiac and Vascular Diseases, John Paul II Hospital
Krakow, Poland, 31-202